Abstract
SummaryTo gain further information about the protective effect of phospholipase C (PLC) against intravascular coagulation, we have carried out studies in sheep. Thromboplastin infusions gave a dose-dependent increase in pulmonary platelet-bound 11 inactivity and a dose-dependent decrease in arterial oxygen tension, factor VIIIc activity, fibrinogen level and platelet count. All these parameters were significantly correlated when doses of 0.4 – 0.5 ml bovine thromboplastin/kg/min were given. The model therefore seemed suitable for testing the effect of PLC in preventing intravascular coagulation elicited by infusion of thromboplastin. Our experiments show that PLC may have a certain protective effect against pulmonary microembolism caused by thromboplastin infusion, but there was no normalization of the pulmonary 111In-radioactivity from labelled platelets, arterial oxygen tension, coagulation factors or platelet count in contrast to earlier observations in rats. Protection was observed against the effect of lethal doses of thromboplastin, but although small doses of PLC were used, both sheep eventually died of PLC toxicity.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
